1 year return (CAGR)
12.38%
Genetic Technologies Ltd Exchange (NASDAQ, USD)
GENE
1952.00
-4.60 (-0.24%)
HealthcareDiagnostics & Research
Loading...
3 year return (CAGR)
353.71%
5 year return (CAGR)
87.60%
10 year return (CAGR)
24.98%
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
9.46B
Price/Sales
695.98
Ent value
9.47B
Price/Book
5169.22
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-69.45%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 1956.80 |
| Daily high | 1956.80 |
| Daily low | 1952.00 |
| Daily Volume | 2K |
| All-time high | 6925.00 |
| 1y analyst estimate | 12.50 |
| Beta | 0.48 |
| EPS (TTM) | -0.12 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| GENE | S&P500 | |
| Current price drop from All-time high | -71.81% | -2.58% |
| Highest price drop | -99.99% | -56.47% |
| Date of highest drop | 8 Aug 2024 | 9 Mar 2009 |
| Avg drop from high | -86.94% | -10.68% |
| Avg time to new high | 822 days | 12 days |
| Max time to new high | 4904 days | 1805 days |
News
No items found